Mitochondrial DNA damage Is associated with reduced mitochondrial bioenergetics in Huntington's disease

被引:113
作者
Siddiqui, Almas [2 ]
Rivera-Sanchez, Sulay [3 ]
Castro, Maria del R. [1 ]
Acevedo-Torres, Karina [4 ]
Rane, Anand [2 ]
Torres-Ramos, Carlos A. [4 ]
Nicholls, David G. [2 ]
Andersen, Julie K. [2 ]
Ayala-Torres, Sylvette [1 ]
机构
[1] Univ Puerto Rico, Dept Pharmacol & Toxicol, San Juan, PR 00936 USA
[2] Buck Inst Age Res, Novato, CA 94945 USA
[3] Univ Puerto Rico, Dept Biochem, San Juan, PR 00936 USA
[4] Univ Puerto Rico, Dept Physiol, San Juan, PR 00936 USA
基金
美国国家卫生研究院;
关键词
Mitochondrial DNA; Huntington's disease; Mitochondrial respiration; Base excision repair; AP endonuclease; Mitochondrial dysfunction; BASE EXCISION-REPAIR; SPARE RESPIRATORY CAPACITY; TRANSGENIC MOUSE MODEL; OXIDATIVE DAMAGE; APURINIC/APYRIMIDINIC ENDONUCLEASE; IN-VIVO; PROTEIN EXPRESSION; BINDING ACTIVITY; STRIATAL CELLS; APE/REF-1;
D O I
10.1016/j.freeradbiomed.2012.06.008
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Oxidative stress and mitochondrial dysfunction have been implicated in the pathology of HD; however, the precise mechanisms by which mutant huntingtin modulates levels of oxidative damage in turn resulting in mitochondrial dysfunction are not known. We hypothesize that mutant huntingtin increases oxidative mtDNA damage leading to mitochondrial dysfunction. We measured nuclear and mitochondrial DNA lesions and mitochondrial bioenergetics in the STHdhQ7 and STHdhQ111 in vitro striatal model of HD. Striatal cells expressing mutant huntingtin show higher basal levels of mitochondrial-generated ROS and mtDNA lesions and a lower spare respiratory capacity. Silencing of APE1, the major mammalian apurinic/apyrimidinic (AP) endonuclease that participates in the base excision repair (BER) pathway, caused further reductions of spare respiratory capacity in the mutant huntingtin-expressing cells. Localization experiments show that APE1 increases in the mitochondria of wild-type Q7 cells but not in the mutant huntingtin Q111 cells after treatment with hydrogen peroxide. Moreover, these results are recapitulated in human HD striata and HD skin fibroblasts that show significant mtDNA damage (increased lesion frequency and mtDNA depletion) and significant decreases in spare respiratory capacity, respectively. These data suggest that mtDNA is a major target of mutant huntingtin-associated oxidative stress and may contribute to subsequent mitochondrial dysfunction and that APE1 (and, by extension, BER) is an important target in the maintenance of mitochondrial function in HD. (C) 2012 Elsevier Inc. All rights reserved.
引用
收藏
页码:1478 / 1488
页数:11
相关论文
共 50 条
[21]   Mitochondrial Dysfunction in Huntington's Disease [J].
Carmo, Catarina ;
Naia, Luana ;
Lopes, Carla ;
Cristina Rego, A. .
POLYGLUTAMINE DISORDERS, 2018, 1049 :59-83
[22]   Mitochondrial dysfunction in Huntington's disease:: the bioenergetics of isolated and in situ mitochondria from transgenic mice [J].
Oliveira, Jorge M. A. ;
Jekabsons, Mika B. ;
Chen, Sylvia ;
Lin, Amy ;
Rego, A. Cristina ;
Goncalves, Jorge ;
Ellerby, Lisa M. ;
Nicholls, David G. .
JOURNAL OF NEUROCHEMISTRY, 2007, 101 (01) :241-249
[23]   Mitochondrial DNA haplogroups do not influence the Huntington's disease phenotype [J].
Mancuso, Michelangelo ;
Kiferle, Lorenzo ;
Petrozzi, Lucia ;
Nesti, Claudia ;
Rocchi, Anna ;
Ceravolo, Roberto ;
Orsucci, Daniele ;
Maluccio, Maria Rosaria ;
Bonuccelli, Ubaldo ;
Filosto, Massimiliano ;
Siciliano, Gabriele ;
Murri, Luigi .
NEUROSCIENCE LETTERS, 2008, 444 (01) :83-86
[24]   Mitochondrial DNA Oxidative Damage and Repair in Aging and Alzheimer's Disease [J].
Santos, Renato X. ;
Correia, Sonia C. ;
Zhu, Xiongwei ;
Smith, Mark A. ;
Moreira, Paula I. ;
Castellani, Rudy J. ;
Nunomura, Akihiko ;
Perry, George .
ANTIOXIDANTS & REDOX SIGNALING, 2013, 18 (18) :2444-2457
[25]   Mitochondrial Abnormalities and Synaptic Damage in Huntington's Disease: a Focus on Defective Mitophagy and Mitochondria-Targeted Therapeutics [J].
Sawant, Neha ;
Morton, Hallie ;
Kshirsagar, Sudhir ;
Reddy, Arubala P. ;
Reddy, P. Hemachandra .
MOLECULAR NEUROBIOLOGY, 2021, 58 (12) :6350-6377
[26]   Mitochondrial and Redox-Based Therapeutic Strategies in Huntington's Disease [J].
Fao, Ligia ;
Rego, Ana Cristina .
ANTIOXIDANTS & REDOX SIGNALING, 2021, 34 (08) :650-673
[27]   Mitochondrial-Associated Metabolic Changes and Neurodegeneration in Huntington's Disease - from Clinical Features to the Bench [J].
Rosenstock, Tatiana R. ;
Duarte, Ana I. ;
Rego, A. Cristina .
CURRENT DRUG TARGETS, 2010, 11 (10) :1218-1236
[28]   Mitochondrial HSF1 triggers mitochondrial dysfunction and neurodegeneration in Huntington's disease [J].
Liu, Chunyue ;
Fu, Zixing ;
Wu, Shanshan ;
Wang, Xiaosong ;
Zhang, Shengrong ;
Chu, Chu ;
Hong, Yuan ;
Wu, Wenbo ;
Chen, Shengqi ;
Jiang, Yueqing ;
Wu, Yang ;
Song, Yongbo ;
Liu, Yan ;
Guo, Xing .
EMBO MOLECULAR MEDICINE, 2022, 14 (07)
[29]   Mitochondrial DNA damage is associated with damage accrual and disease duration in patients with Systemic Lupus Erythematosus [J].
Lopez-Lopez, L. ;
Nieves-Plaza, M. ;
Castro, M. del R. ;
Font, Y. M. ;
Torres-Ramos, C. A. ;
Vila, L. M. ;
Ayala-Pena, S. .
LUPUS, 2014, 23 (11) :1133-1141
[30]   Age-associated change in mitochondrial DNA damage [J].
Hudson, EK ;
Hogue, BA ;
Souza-Pinto, NC ;
Croteau, DL ;
Anson, RM ;
Bohr, VA ;
Hansford, RG .
FREE RADICAL RESEARCH, 1998, 29 (06) :573-579